Oxford Vaccine Might Be Ready For Distribution In Kenya By January

According to members of the national Covid-19 vaccines Taskforce, the AstraZeneca-Oxford vaccine may be ready for distribution in Kenya by January or February 2021.
“If all things go as planned, it may be ready for distribution in Kenya by January or February next year. We will give frontline workers, old people, and those with comorbidities priority,” the official said
British drugs group AstraZeneca and the University of Oxford say their jointly-developed vaccine against COVID-19 has shown “an average efficacy of 70 percent” in trials.
“This vaccine’s efficacy and safety confirm that it will be highly effective against COVID-19 and will have an immediate impact on this public health emergency,” AstraZeneca chief executive Pascal Soriot said in a statement on Monday.
The official said that would immediately grant the emergency use authorization of the vaccine if AstraZeneca gets such approval from US or UK governments. This will allow shots to be given to certain people while studies of safety and effectiveness are ongoing.
They said it will immediately apply for early approval of the vaccine where possible, and it will seek an emergency use listing from the World Health Organization, so it can make the shot available in low-income countries.
AstraZeneca, which has pledged it won’t make a profit on the vaccine during the pandemic, has reached agreements with governments and international health organizations that put its cost at less than 300 shillings per dose.
British and EU regulators have been conducting rolling reviews of the vaccine, which could fast-track the process.
According to AstraZeneca, it will share its trial data with the US Food and Drug Administration but did not say when it would apply for authorization for emergency use there.
Kenya is relying on a supply network called Covax facility, organized by Gavi, the World Health Organisation, and Unicef and supported by Bill and Melinda Gates Foundation among other institutions.
The facility says it has already secured millions of ready-made doses of the Oxford-AstraZeneca candidate, ready for distribution to 92 developing countries. It will buy vaccines, discount the price and sell to Kenya at about Sh300 per dose.
The good thing about the Oxford vaccine, it is cheap and it can be stored, transported, and handled “at normal refrigerated conditions” of between two and eight degrees Celsius for at least six months.
AstraZeneca said it would immediately prepare the regulatory submission of the data to authorities around the world that have a framework in place for conditional or early approval.
- January 2025 (119)
- February 2025 (120)
- January 2024 (238)
- February 2024 (227)
- March 2024 (190)
- April 2024 (133)
- May 2024 (157)
- June 2024 (145)
- July 2024 (136)
- August 2024 (154)
- September 2024 (212)
- October 2024 (255)
- November 2024 (196)
- December 2024 (143)
- January 2023 (182)
- February 2023 (203)
- March 2023 (322)
- April 2023 (298)
- May 2023 (268)
- June 2023 (214)
- July 2023 (212)
- August 2023 (257)
- September 2023 (237)
- October 2023 (264)
- November 2023 (286)
- December 2023 (177)
- January 2022 (293)
- February 2022 (329)
- March 2022 (358)
- April 2022 (292)
- May 2022 (271)
- June 2022 (232)
- July 2022 (278)
- August 2022 (253)
- September 2022 (246)
- October 2022 (196)
- November 2022 (232)
- December 2022 (167)
- January 2021 (182)
- February 2021 (227)
- March 2021 (325)
- April 2021 (259)
- May 2021 (285)
- June 2021 (272)
- July 2021 (277)
- August 2021 (232)
- September 2021 (271)
- October 2021 (304)
- November 2021 (364)
- December 2021 (249)
- January 2020 (272)
- February 2020 (310)
- March 2020 (390)
- April 2020 (321)
- May 2020 (335)
- June 2020 (327)
- July 2020 (333)
- August 2020 (276)
- September 2020 (214)
- October 2020 (233)
- November 2020 (242)
- December 2020 (187)
- January 2019 (251)
- February 2019 (215)
- March 2019 (283)
- April 2019 (254)
- May 2019 (269)
- June 2019 (249)
- July 2019 (335)
- August 2019 (293)
- September 2019 (306)
- October 2019 (313)
- November 2019 (362)
- December 2019 (318)
- January 2018 (291)
- February 2018 (213)
- March 2018 (275)
- April 2018 (223)
- May 2018 (235)
- June 2018 (176)
- July 2018 (256)
- August 2018 (247)
- September 2018 (255)
- October 2018 (282)
- November 2018 (282)
- December 2018 (184)
- January 2017 (183)
- February 2017 (194)
- March 2017 (207)
- April 2017 (104)
- May 2017 (169)
- June 2017 (205)
- July 2017 (189)
- August 2017 (195)
- September 2017 (186)
- October 2017 (235)
- November 2017 (253)
- December 2017 (266)
- January 2016 (164)
- February 2016 (165)
- March 2016 (189)
- April 2016 (143)
- May 2016 (245)
- June 2016 (182)
- July 2016 (271)
- August 2016 (247)
- September 2016 (233)
- October 2016 (191)
- November 2016 (243)
- December 2016 (153)
- January 2015 (1)
- February 2015 (4)
- March 2015 (164)
- April 2015 (107)
- May 2015 (116)
- June 2015 (119)
- July 2015 (145)
- August 2015 (157)
- September 2015 (186)
- October 2015 (169)
- November 2015 (173)
- December 2015 (205)
- March 2014 (2)
- March 2013 (10)
- June 2013 (1)
- March 2012 (7)
- April 2012 (15)
- May 2012 (1)
- July 2012 (1)
- August 2012 (4)
- October 2012 (2)
- November 2012 (2)
- December 2012 (1)